Vaccine
Synparv-MR
Inactivated parvovirus vaccine and erysipelas in pigs as emulsion for injection
The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.
*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..
Quick product information
| Active ingredient(s) | Posology* | Waiting time | Packaging |
|---|---|---|---|
Inactivated porcine parvovirus strain PPV7 | Intramuscular or subcutaneous route | Zero days | 10 ml (5 doses) 20 ml (10 doses) 50 mL (25 doses) |
Country Availability
Malta, Russia, Spain, Thailand, Belarus.
If your country is not listed, please contact our export team.
Active ingredient(s)
Inactivated porcine parvovirus strain PPV7 >1 RP*
Inactivated Erysipelothrix Rhusiopathiae serotype 2 strain S10R >1 RP*
*Relative potency compared to the reference vaccine
Indications
For active immunisation of pigs to prevent infection against parvovirus and infections caused by Erysipelothrix rhusiopathiae.
Onset of immunity: 8 weeks after the primary vaccination.
Duration of immunity: 4 months after the primary vaccination.
Posology
Shake the veterinary medicinal product before use.
The applicable dose will be 2 ml per animal in all cases, administered by intramuscular or subcutaneous injection
Vaccination course
Nulliparous pigs:Primary vaccination with a dose at 6-7 months of age and a second dose administered 3 weeks later.
Multiparous pigs: Administer one dose 2-3 weeks before mating
Boars: Primary vaccination with a dose at 6-7 months of age and a second dose administered 3 weeks later.
Revaccinate annually
Waiting time
Zero days.
Packaging
Containers with 10 ml (5 doses) and 50 ml (25 doses).
With veterinary prescription.
Registry no.: 2954 ESP
